INVOKANA
NDC 50458-141, canagliflozin, tablet, film coated, from Janssen Pharmaceuticals, Inc..
- Product NDC
- 50458-141
- Status
- Listed
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204042
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50458-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANAGLIFLOZIN300 mg/1
Pharmacologic classes
P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50458-141-01 | 50458014101 | 5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01) |
| 50458-141-10 | 50458014110 | 10 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 50458-141-30 | 50458014130 | 30 TABLET, FILM COATED in 1 BOTTLE (50458-141-30) |
| 50458-141-50 | 50458014150 | 500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50) |
| 50458-141-90 | 50458014190 | 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b9057d3b-b104-4f09-8a61-c61ef9d4a3f3NADAC price for package 50458014130
GET /v1/drugs/nadac/50458014130NADAC price for package 50458014190
GET /v1/drugs/nadac/50458014190
Use it
Look up 50458-141 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50458-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50458-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.